Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 78
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Ann Hematol ; 101(10): 2209-2218, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36040481

RESUMEN

The coincident downregulation of NR4A1 and NR4A3 has been implicated in myeloid leukemogenesis, but it remains unknown how these two genes function in myeloid cells and how their combined downregulation promotes myeloid leukemogenesis. Since NR4A1 abrogation is thought to confer a survival and proliferation advantage to myeloid cells, we hypothesized that downregulation of NR4A3 may have a complementary effect on myeloid cell differentiation. First, we tested the association between differentiation status of leukemic cells and NR4A3 expression using two large clinical datasets from patients with different acute myeloid leukemia (AML) subtypes. The analysis revealed a close association between differentiation status and different subtypes of AML Then, we probed the effects of differentiation-inducing treatments on NR4A3 expression and NR4A3 knockdown on cell differentiation using two myeloid leukemia cell lines. Differentiation-inducing treatments caused upregulation of NR4A3, while NR4A3 knockdown prevented differentiation in both cell lines. The cell culture findings were validated using samples from chronic myeloid leukemia (CML) patients at chronic, accelerated and blastic phases, and in acute promyelocytic leukemia (APL) patients before and after all trans-retinoic acid (ATRA)-based differentiation therapy. Progressive NR4A3 downregulation was coincident with impairments in differentiation in patients during progression to blastic phase of CML, and NR4A3 expression was increased in APL patients treated with ATRA-based differentiating therapy. Together, our findings demonstrate a tight association between impaired differentiation status and NR4A3 downregulation in myeloid leukemias, providing a plausible mechanistic explanation of how myeloid leukemogenesis might occur upon concurrent downregulation of NR4A1 and NR4A3.


Asunto(s)
Leucemia Mielógena Crónica BCR-ABL Positiva , Leucemia Mieloide Aguda , Leucemia Promielocítica Aguda , Receptores de Esteroides , Diferenciación Celular/genética , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Regulación hacia Abajo , Humanos , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Leucemia Mieloide Aguda/tratamiento farmacológico , Leucemia Mieloide Aguda/genética , Leucemia Promielocítica Aguda/tratamiento farmacológico , Receptores de Esteroides/genética , Receptores de Esteroides/metabolismo , Receptores de Esteroides/uso terapéutico , Receptores de Hormona Tiroidea/genética , Receptores de Hormona Tiroidea/metabolismo , Receptores de Hormona Tiroidea/uso terapéutico , Tretinoina/farmacología
2.
FASEB J ; 34(9): 12072-12082, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32776612

RESUMEN

Mammals adapt to seasons using a neuroendocrine calendar defined by the photoperiodic change in the nighttime melatonin production. Under short photoperiod, melatonin inhibits the pars tuberalis production of TSHß, which, in turn, acts on tanycytes to regulate the deiodinase 2/3 balance resulting in a finely tuned seasonal control of the intra-hypothalamic thyroid hormone T3. Despite the pivotal role of this T3 signaling for synchronizing reproduction with the seasons, T3 cellular targets remain unknown. One candidate is a population of hypothalamic neurons expressing Rfrp, the gene encoding the RFRP-3 peptide, thought to be integral for modulating rodent's seasonal reproduction. Here we show that nighttime melatonin supplementation in the drinking water of melatonin-deficient C57BL/6J mice mimics photoperiodic variations in the expression of the genes Tshb, Dio2, Dio3, and Rfrp, as observed in melatonin-proficient mammals. Notably, we report that this melatonin regulation of Rfrp expression is no longer observed in mice carrying a global mutation of the T3 receptor, TRα, but is conserved in mice with a selective neuronal mutation of TRα. In line with this observation, we find that TRα is widely expressed in the tanycytes. Altogether, our data demonstrate that the melatonin-driven T3 signal regulates RFRP-3 neurons through non-neuronal, possibly tanycytic, TRα.


Asunto(s)
Regulación de la Expresión Génica/efectos de los fármacos , Melatonina/farmacología , Neuropéptidos/biosíntesis , Receptores de Hormona Tiroidea/metabolismo , Triyodotironina/metabolismo , Animales , Yoduro Peroxidasa/genética , Yoduro Peroxidasa/metabolismo , Ratones , Ratones Noqueados , Neuropéptidos/genética , Receptores de Hormona Tiroidea/genética , Triyodotironina/genética , Yodotironina Deyodinasa Tipo II
3.
FASEB J ; 34(4): 4997-5015, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32052887

RESUMEN

Development of the songbird brain provides an excellent experimental model for understanding the regulation of sex differences in ontogeny. Considering the regulatory role of the hypothalamus in endocrine, in particular reproductive, physiology, we measured the structural (volume) and molecular correlates of hypothalamic development during ontogeny of male and female zebra finches. We quantified by relative quantitative polymerase chain reaction (rqPCR) the expression of 14 genes related to thyroid and steroid hormones actions as well as 12 genes related to brain plasticity at four specific time points during ontogeny and compared these expression patterns with the expression of the same genes as detected by transcriptomics in the telencephalon. These two different methodological approaches detected specific changes with age and demonstrated that in a substantial number of cases changes observed in both brain regions are nearly identical. Other genes however had a tissue-specific developmental pattern. Sex differences or interactions of sex by age were detected in the expression of a subset of genes, more in hypothalamus than telencephalon. These results correlate with multiple known aspects of the developmental and reproductive physiology but also raise a number of new functional questions.


Asunto(s)
Hipotálamo/metabolismo , Desarrollo Sexual , Telencéfalo/metabolismo , Transcriptoma , Animales , Femenino , Pinzones , Regulación del Desarrollo de la Expresión Génica , Hipotálamo/crecimiento & desarrollo , Masculino , Receptores de Hormona Tiroidea/genética , Receptores de Hormona Tiroidea/metabolismo , Caracteres Sexuales , Telencéfalo/crecimiento & desarrollo
4.
Int J Radiat Biol ; 95(12): 1696-1707, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31498019

RESUMEN

Purpose: Hyperthermia (HT), a clinical treatment involving delivery of heat to tumors, has been used in combination with traditional chemotherapy and radiotherapy to enhance their effects. However, the molecular mechanism underlying the high efficacy of combination therapy is not clear. This study was conducted to identify the molecular mechanism underlying the sensitization of lung cancer to radiotherapy by HT.Materials and methods: Nuclear receptor subfamily 4, group A, member 3 (NR4A3) and Krüppel-like factor 11 (KLF11) expression in non-small-cell lung cancer cells was confirmed by performing real-time quantitative reverse transcription-polymerase chain reaction. Tumor cell proliferation and apoptosis were assessed via a colony-forming assay and Annexin V/propidium iodide staining.Results and conclusions: Expression profile analysis revealed elevated levels of NR4A3 and KLF11 in A549 lung cancer cells after treatment with HT combined with radiation. We also confirmed that NR4A3 and KLF11 induced apoptosis and inhibited cell proliferation by elevating intracellular reactive oxygen species levels. Knockdown of NR4A3 or KLF11 using siRNA led to decreased effects of radiohyperthermia. Finally, the effect of these two factors on lung cancer progression was evaluated by in vivo xenograft studies. Taken together, the results suggest that NR4A3 and KLF11 are critical for increasing the efficacy of radiotherapy in combination with HT.


Asunto(s)
Proteínas Reguladoras de la Apoptosis/genética , Proteínas de Unión al ADN/genética , Progresión de la Enfermedad , Regulación Neoplásica de la Expresión Génica/efectos de la radiación , Hipertermia Inducida , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/radioterapia , Receptores de Esteroides/genética , Receptores de Hormona Tiroidea/genética , Proteínas Represoras/genética , Células A549 , Animales , Apoptosis/efectos de la radiación , Proliferación Celular/efectos de la radiación , Transformación Celular Neoplásica , Terapia Combinada , Humanos , Neoplasias Pulmonares/genética , Masculino , Ratones
5.
Ecotoxicol Environ Saf ; 164: 500-509, 2018 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-30145490

RESUMEN

Mercury is severely detrimental to organisms and is ubiquitous in both terrestrial and aquatic ecosystems. In the present study, we examined the effects of chronic mercury (Hg) exposure on metamorphosis, body size, thyroid microstructures, liver microstructural and ultrastructural features, and transcript levels of genes associated with lipid metabolism, oxidative stress and thyroid hormones signaling pathways of Chinese toad (Bufo gargarizans) tadpoles. Tadpoles were exposed to mercury concentrations at 0, 6, 12, 18, 24 and 30 µg/L from Gosner stage 26-42 of metamorphic climax. The present results showed that high dose mercury (24 and 30 µg/L) decelerated metamorphosis rate and inhibited body size of B. gargarizans larvae. Histological examinations have clearly exhibited that high mercury concentrations caused thyroid gland and liver damages. Moreover, degeneration and disintegration of hepatocytes, mitochondrial vacuolation, and endoplasmic reticulum breakdown were visible in the ultrastructure of liver after high dose mercury treatment. Furthermore, the larvae exposed to high dose mercury demonstrated a significant decrease in type II iodothyronine deiodinase (Dio2) and thyroid hormone receptor α and ß (TRα and TRß) mRNA levels. Transcript level of superoxide dismutase (SOD) and heat shock protein (HSP) were significantly up regulated in larvae exposed to high dose mercury, while transcript level of phospholipid hydroperoxide glutathione peroxidase (PHGPx) was significantly down regulated. Moreover, exposure to high dose mercury significantly down regulated mRNA expression of carnitine palmitoyltransferase (CPT), sterol carrier protein (SCP), acyl-CoA oxidase (ACOX) and peroxisome proliferator-activated receptor α (PPAPα), but significantly up regulated mRNA expression of fatty acid elongase (FAE), fatty acid synthetase (FAS) and Acetyl CoA Carboxylase (ACC). Therefore, we conclude that high dose mercury induced thyroid function disruption, liver oxidative stress and lipid metabolism disorder by damaging thyroid and liver cell structures and altering the expression levels of relevant genes.


Asunto(s)
Metabolismo de los Lípidos/efectos de los fármacos , Hígado/efectos de los fármacos , Mercurio/toxicidad , Estrés Oxidativo , Glándula Tiroides/efectos de los fármacos , Animales , Bufonidae , Glutatión Peroxidasa/genética , Glutatión Peroxidasa/metabolismo , Yoduro Peroxidasa/genética , Yoduro Peroxidasa/metabolismo , Larva/efectos de los fármacos , Larva/genética , Larva/metabolismo , Larva/ultraestructura , Hígado/patología , Hígado/ultraestructura , Metamorfosis Biológica/efectos de los fármacos , Fosfolípido Hidroperóxido Glutatión Peroxidasa , ARN Mensajero/metabolismo , Receptores de Hormona Tiroidea/genética , Superóxido Dismutasa/metabolismo , Glándula Tiroides/patología , Yodotironina Deyodinasa Tipo II
6.
Endocr J ; 65(8): 805-813, 2018 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-29794369

RESUMEN

Mutations in TBL1X, a component of the nuclear receptor co-repressor (N-CoR) and silencing mediator of retinoic acid and thyroid hormone receptor co-repressor complexes, have recently been implicated in isolated central hypothyroidism (CeH). However, the mechanisms by which TBL1X mutations affect negative feedback regulation in the hypothalamus-pituitary-thyroid axis remain unclear. N-CoR was previously reported to paradoxically enhance the ligand-independent stimulation of TRH and TSHß gene promoters by thyroid hormone receptors (TR) in cell culture systems. We herein investigated whether TBL1X affects the unliganded TR-mediated stimulation of the promoter activities of genes negatively regulated by T3 in cooperation with N-CoR. In a hypothalamic neuronal cell line, the unliganded TR-mediated stimulation of the TRH gene promoter was significantly enhanced by co-transfected TBL1X, and the co-transfection of TBL1X with N-CoR further enhanced promoter activity. In contrast, the knockdown of endogenous Tbl1x using short interfering RNA significantly attenuated the N-CoR-mediated enhancement of promoter activity in the presence of unliganded TR. The co-transfection of N365Y or Y458C, TBL1X mutants identified in CeH patients, showed impaired co-activation with N-CoR for the ligand-independent stimulation of the TRH promoter by TR. In the absence of T3, similar or impaired enhancement of the TSHß gene promoter by the wild type or TBL1X mutants, respectively, was observed in the presence of co-transfected TR and N-CoR in CV-1 cells. These results suggest that TBL1X is needed for the full activation of TRH and TSHß gene promoters by unliganded TR. Mutations in TBL1X may cause CeH due to the impaired up-regulation of TRH and/or TSHß gene transcription despite low T3 levels.


Asunto(s)
Regiones Promotoras Genéticas , Receptores de Hormona Tiroidea/genética , Tirotropina de Subunidad beta/genética , Hormona Liberadora de Tirotropina/genética , Transducina/genética , Animales , Línea Celular , Regulación de la Expresión Génica , Hipotálamo/citología , Hipotálamo/metabolismo , Ratones , Neuronas/citología , Neuronas/metabolismo , ARN Interferente Pequeño , Receptores de Hormona Tiroidea/metabolismo , Tirotropina de Subunidad beta/metabolismo , Hormona Liberadora de Tirotropina/metabolismo , Transducina/metabolismo
7.
J Trace Elem Med Biol ; 47: 89-97, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29544812

RESUMEN

OBJECTIVE: Our aim was to investigate thyroid function alterations attributed to high iodide supplementation in maternal rats and their offspring. METHODS: Depending on their iodide intake, the pregnant rats were randomly divided into three groups: normal iodide intake (NI), 10 times high iodide intake (10 HI) and 100 times high iodide intake (100 HI) groups. Iodine concentration in the urine and maternal milk; iodine content and mitochondrial superoxide production; expression of TRα1, TRß1, NIS and Dio1 in both the thyroid and mammary glands were all measured. The offspring were exposed to different iodide-containing water (NI, 10 HI and 100 HI) from weaning to postnatal day 180 (PN180). Serum thyroid hormone levels were measured in both maternal rats and their offspring. RESULTS: Iodine concentration in the urine and maternal milk, as well as iodine content in the thyroid and mammary glands was significantly increased in both the 10 HI and 100 HI groups (p < .05). In the 100 HI group of maternal rats, low FT3 levels, high FT4, TPOAb and TgAb levels were detected. In addition, an increased mitochondrial superoxide production and decreased expression of TRα1, TRß1, NIS and Dio1 in the thyroid and mammary glands was found (p < .05). A positive staining of CD4+ that co-localized with TRß1 in the infiltrated cells within the thyroid follicles was observed. At PN180 in the offspring, the FT3 and FT4 levels showed a significant decrease, while the levels of serum TSH, TPOAb and TgAb were significantly increased in both 10 HI and 100 HI groups (p < .05). CONCLUSION: In maternal rats, although normal thyroid function can be maintained following 10 HI, thyroiditis can be induced following 100 HI on lactation days 7, 14, and 21. In the offspring at PN180, hypothyroidism complicated with thyroiditis can occur in both the 10 HI and 100 HI groups.


Asunto(s)
Yodo/administración & dosificación , Glándulas Mamarias Animales/efectos de los fármacos , Glándula Tiroides/efectos de los fármacos , Animales , Animales Recién Nacidos , Femenino , Hipotiroidismo/inducido químicamente , Yoduro Peroxidasa/genética , Yodo/análisis , Yodo/orina , Masculino , Glándulas Mamarias Animales/metabolismo , Leche/química , Ratas Wistar , Receptores de Hormona Tiroidea/genética , Superóxidos/metabolismo , Pruebas de Función de la Tiroides , Glándula Tiroides/fisiología , Tiroxina/análisis , Triyodotironina/análisis
8.
Mol Cell Endocrinol ; 459: 28-42, 2017 Dec 25.
Artículo en Inglés | MEDLINE | ID: mdl-28630022

RESUMEN

As one of the most basal living vertebrates, lampreys represent an excellent model system to study the evolution of thyroid hormone (TH) signaling. The lamprey hypothalamic-pituitary-thyroid and reproductive axes overlap functionally. Lampreys have 3 gonadotropin-releasing hormones and a single glycoprotein hormone from the hypothalamus and pituitary, respectively, that regulate both the reproductive and thyroid axes. TH synthesis in larval lampreys takes place in an endostyle that transforms into typical vertebrate thyroid tissue during metamorphosis; both the endostyle and follicular tissue have all the typical TH synthetic components found in other vertebrates. Furthermore, lampreys also have the vertebrate suite of peripheral regulators including TH distributor proteins (THDPs), deiodinases and TH receptors (TRs). Although at the molecular level the components of the lamprey thyroid system are ancestral to other vertebrates, their functions have been largely conserved. TH signaling as it relates to lamprey metamorphosis represents a particularly interesting phenomenon. Unlike other metamorphosing vertebrates, lamprey THs increase throughout the larval period, peak prior to metamorphosis and decline rapidly at the onset of metamorphosis; patterns of deiodinase activity are consistent with these increases and declines. Moreover, goitrogens (which suppress TH levels) initiate precocious metamorphosis, and exogenous TH treatment blocks goitrogen-induced metamorphosis and disrupts natural metamorphosis. Despite this clear physiological difference, TH action via TRs is consistent with higher vertebrates. Based on observations that TRs are upregulated in a tissue-specific fashion during morphogenesis and the finding that lamprey TRs upregulate genes via THs in a fashion similar to higher vertebrates, we propose the following hypothesis for further testing. THs have a dual role in lampreys where high TH levels promote larval feeding and growth and then at the onset of metamorphosis TH levels decrease rapidly; at this time the relatively low TH levels function via TRs in a fashion similar to that of other metamorphosing vertebrates.


Asunto(s)
Lampreas/metabolismo , Sistemas Neurosecretores/fisiología , Receptores de Hormona Tiroidea/metabolismo , Reproducción/fisiología , Transducción de Señal , Hormonas Tiroideas/metabolismo , Animales , Conducta Alimentaria/fisiología , Regulación del Desarrollo de la Expresión Génica , Hipotálamo/fisiología , Yoduro Peroxidasa/genética , Yoduro Peroxidasa/metabolismo , Lampreas/genética , Lampreas/crecimiento & desarrollo , Larva/genética , Larva/crecimiento & desarrollo , Larva/metabolismo , Metamorfosis Biológica/fisiología , Hipófisis/fisiología , Hormonas Hipofisarias/genética , Hormonas Hipofisarias/metabolismo , Receptores de Hormona Tiroidea/genética , Glándula Tiroides/fisiología , Hormonas Tiroideas/genética
9.
Mol Cell Endocrinol ; 459: 71-78, 2017 Dec 25.
Artículo en Inglés | MEDLINE | ID: mdl-28153797

RESUMEN

Thyroid hormones (THs) are important mediators of vertebrate central nervous system (CNS) development, thereby regulating the expression of a wide variety of genes by binding to nuclear TH receptors. TH transporters and deiodinases are both needed to ensure appropriate intracellular TH availability, but the precise function of each of these regulators and their coaction during brain development is only partially understood. Rodent knockout models already provided some crucial insights, but their in utero development severely hampers research regarding the role of TH regulators during early embryonic stages. The establishment of novel gain- and loss-of-function techniques has boosted the position of externally developing non-mammalian vertebrates as research models in developmental endocrinology. Here, we elaborate on the chicken as a model organism to elucidate the function of TH regulators during embryonic CNS development. The fast-developing, relatively big and accessible embryo allows easy experimental manipulation, especially at early stages of brain development. Recent data on the characterisation and spatiotemporal expression pattern of different TH regulators in embryonic chicken CNS have provided the necessary background to dissect the function of each of them in more detail. We highlight some recent advances and important strategies to investigate the role of TH transporters and deiodinases in various CNS structures like the brain barriers, the cerebellum, the retina and the hypothalamus. Exploiting the advantages of this non-classical model can greatly contribute to complete our understanding of the regulation of TH bioavailability throughout embryonic CNS development.


Asunto(s)
Proteínas Portadoras/genética , Cerebelo/metabolismo , Hipotálamo/metabolismo , Yoduro Peroxidasa/genética , Receptores de Hormona Tiroidea/genética , Hormonas Tiroideas/genética , Animales , Proteínas Portadoras/metabolismo , Cerebelo/crecimiento & desarrollo , Embrión de Pollo , Electroporación/métodos , Desarrollo Embrionario , Regulación del Desarrollo de la Expresión Génica , Silenciador del Gen , Hipotálamo/crecimiento & desarrollo , Yoduro Peroxidasa/metabolismo , Modelos Biológicos , Receptores de Hormona Tiroidea/metabolismo , Retina/crecimiento & desarrollo , Retina/metabolismo , Transducción de Señal , Hormonas Tiroideas/metabolismo
10.
Bioelectromagnetics ; 38(2): 137-150, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27973686

RESUMEN

Optimal therapeutics for hyperthyroidism-induced osteoporosis are still lacking. As a noninvasive treatment, electromagnetic fields (EMF) have been proven to be effective for treating osteoporosis in non-hyperthyroidism conditions. We herein systematically evaluated the reduced effects of EMF on osteoporosis in a hyperthyroidism rat model. With the use of Helmholtz coils and an EMF stimulator, 15 Hz/1 mT EMF was generated. Forty-eight 5-month-old male Sprague-Dawley rats were randomly divided into four different groups: control, levothyroxine treated (L-T4), EMF exposure + levothyroxine (EMF + L-T4), and EMF exposure without levothyroxine administration (EMF). All rats were treated with L-T4 (100 mg/day) except those in control and EMF groups. After 12 weeks, the results obtained from bone mineral density analyses and bone mechanical measurements showed significant differences between L-T4 and EMF + L-T4 groups. Micro CT and bone histomorphometric analyses indicated that trabecular bone mass and architecture in distal femur and proximal tibia were augmented and restored partially in EMF + L-T4 group. In addition, bone thyroid hormone receptors (THR) expression of hyperthyroidism rats was attenuated in EMF + L-T4 group, compared to control group, which was not observed in L-T4 group. According to these results, we concluded that 15 Hz/1 mT EMF significantly inhibited bone loss and micro architecture deterioration in hyperthyroidism rats, which might occur due to reduced THR expression caused by EMF exposure. Bioelectromagnetics. 38:137-150, 2017. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Hipertiroidismo/complicaciones , Magnetoterapia , Osteoporosis/etiología , Osteoporosis/terapia , Animales , Densidad Ósea/efectos de la radiación , Modelos Animales de Enfermedad , Regulación de la Expresión Génica/efectos de la radiación , Hipertiroidismo/sangre , Hipertiroidismo/orina , Masculino , Osteoclastos/patología , Osteoclastos/efectos de la radiación , Osteoporosis/metabolismo , Osteoporosis/fisiopatología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores de Hormona Tiroidea/genética , Tibia/metabolismo , Tibia/fisiopatología , Tibia/efectos de la radiación
11.
J Sci Food Agric ; 96(8): 2889-95, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26374392

RESUMEN

BACKGROUND: Cinnamon has several effects on energy metabolism. However, no data exist on the impact of cinnamon intake on thyroid hormone serum concentrations and action, since thyroid hormones (THs) play a major role in metabolism. RESULTS: Male rats were treated with cinnamon water extract (400 mg kg(-1) body weight, 25 days). Cinnamon supplementation resulted in a lower serum total T3 level accompanied by normal serum T4 and TSH levels. The cinnamon-treated rats did not exhibit significant differences in TSHß subunit, TRß or deiodinase type 2 mRNA expression in the pituitary. In the liver, cinnamon did not change the TRß protein expression or the deiodinase type 1 mRNA expression, suggesting that there were no changes in T3 signaling or metabolism in this organ. However, mitochondrial GPDH, a target gene for T3 in the liver, exhibited no changes in mRNA expression, although its activity level was reduced by cinnamon. In the cardiac ventricle, T3 action was markedly reduced by cinnamon, as demonstrated by the lower TRα mRNA and protein levels, reduced SERCA2a and RyR2 and increased phospholamban mRNA expression. CONCLUSION: This study has revealed that TH action is a novel target of cinnamon, demonstrating impairment of T3 signaling in the cardiac ventricles. © 2015 Society of Chemical Industry.


Asunto(s)
Cinnamomum zeylanicum , Regulación de la Expresión Génica/efectos de los fármacos , Receptores de Hormona Tiroidea/metabolismo , Triyodotironina/sangre , Animales , Suplementos Dietéticos , Glicerolfosfato Deshidrogenasa/genética , Glicerolfosfato Deshidrogenasa/metabolismo , Corazón/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Mitocondrias Hepáticas , Miocardio/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Receptores de Hormona Tiroidea/genética , Tirotropina/sangre , Tirotropina/metabolismo , Tiroxina/sangre , Tiroxina/metabolismo
12.
Glia ; 63(5): 906-20, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25643925

RESUMEN

L-tri-iodothyronine (3, 3', 5-triiodothyronine; T3) is an active form of the thyroid hormone (TH) essential for the development and function of the CNS. Though nongenomic effect of TH, its plasma membrane-bound receptor, and its signaling has been identified, precise function in each cell type of the CNS remained to be investigated. Clearance of cell debris and apoptotic cells by microglia phagocytosis is a critical step for the restoration of damaged neuron-glia networks. Here we report nongenomic effects of T3 on microglial functions. Exposure to T3 increased migration, membrane ruffling and phagocytosis of primary cultured mouse microglia. Injection of T3 together with stab wound attracted more microglia to the lesion site in vivo. Blocking TH transporters and receptors (TRs) or TRα-knock-out (KO) suppressed T3-induced microglial migration and morphological change. The T3-induced microglial migration or membrane ruffling was attenuated by inhibiting Gi /o -protein as well as NO synthase, and subsequent signaling such as phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK). Inhibitors for Na(+) /K(+) -ATPase, reverse mode of Na(+) /Ca(2+) exchanger (NCX), and small-conductance Ca(2+) -dependent K(+) (SK) channel also attenuated microglial migration or phagocytosis. Interestingly, T3-induced microglial migration, but not phagocytosis, was dependent on GABAA and GABAB receptors, though GABA itself did not affect migratory aptitude. Our results demonstrate that T3 modulates multiple functional responses of microglia via multiple complex mechanisms, which may contribute to physiological and/or pathophysiological functions of the CNS.


Asunto(s)
Movimiento Celular/efectos de los fármacos , Microglía/efectos de los fármacos , Fagocitosis/efectos de los fármacos , Triyodotironina/farmacología , Adenosina Trifosfato/farmacología , Adyuvantes Farmacéuticos/farmacología , Animales , Lesiones Encefálicas/tratamiento farmacológico , Lesiones Encefálicas/metabolismo , Lesiones Encefálicas/patología , Células Cultivadas , Modelos Animales de Enfermedad , Inhibidores Enzimáticos/farmacología , Femenino , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microglía/fisiología , Probenecid/farmacología , Receptores de Hormona Tiroidea/deficiencia , Receptores de Hormona Tiroidea/genética , Receptores de Hormona Tiroidea/metabolismo , Transducción de Señal/efectos de los fármacos , Tiroxina/farmacología
13.
J Periodontol ; 85(5): e144-51, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24359167

RESUMEN

BACKGROUND: Dental follicle cells (DFCs) are neural crest cell-derived cells and the genuine precursor cells of cementoblast and alveolar osteoblasts. After osteogenic differentiation, expression levels of the transcription factor zinc factor and BTB domain containing 16 (ZBTB16) were significantly increased. ZBTB16 is associated with the process of osteogenic differentiation in bone marrow-derived mesenchymal stem cells and crucial for the expression of the osteogenic transcription factor runt-related transcription factor 2 (RUNX2). It is proposed that ZBTB16 plays also a crucial role for the differentiation of DFCs into osteoblasts. METHODS: In this study, the differentiation of DFCs by alkaline phosphatase (ALP) activity measurement, alizarin red staining, and electron-dispersive x-ray spectrometry (EDX) analysis is investigated. The expression of ZBTB16 during osteogenic differentiation and the expression of osteogenic differentiation markers were assessed by real-time reverse transcription polymerase chain reaction. Glucocorticoid stimulation was inhibited using RU486 (11ß-[p-(Dimethylamino)phenyl]-17ß-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one), and ZBTB16 was overexpressed via transient transfection of an expression vector. RESULTS: After the initiation of osteogenic differentiation, ZBTB16 levels were increased highly in DFCs, whereas RUNX2 was expressed constitutively only. An EDX analysis verified the differentiation of DFCs into osteoblast-like cells because clusters of mineralization consisted of hydroxyapatite. ZBTB16 induced the expression of nuclear receptor subfamily 4, group A, member 3; osteocalcin; and stanniocalcin 1 (STC1) but not of RUNX2 and ALP in DFCs. STC1 was upregulated in DFCs downstream of ZBTB16 and after the osteogenic differentiation. The overexpression of STC1 in DFCs increased the expression of ZBTB16 and specific markers for biomineralization. CONCLUSIONS: The present study shows that ZBTB16 induced the expression of osteogenic differentiation markers independently of RUNX2. Moreover, STC1 is a new candidate for the evaluation of late mechanisms of osteogenic differentiation downstream of ZBTB16.


Asunto(s)
Subunidad alfa 1 del Factor de Unión al Sitio Principal/fisiología , Saco Dental/citología , Factores de Transcripción de Tipo Kruppel/fisiología , Osteoblastos/fisiología , Osteogénesis/genética , Células Madre/fisiología , Fosfatasa Alcalina/análisis , Antraquinonas , Biomarcadores/análisis , Calcificación Fisiológica/genética , Calcio/análisis , Diferenciación Celular/genética , Colorantes , Proteínas de Unión al ADN/genética , Saco Dental/metabolismo , Durapatita/metabolismo , Regulación de la Expresión Génica/genética , Vectores Genéticos/genética , Glucocorticoides/antagonistas & inhibidores , Glicoproteínas/genética , Antagonistas de Hormonas/farmacología , Humanos , Factores de Transcripción de Tipo Kruppel/genética , Mifepristona/farmacología , Osteocalcina/genética , Fósforo/análisis , Proteína de la Leucemia Promielocítica con Dedos de Zinc , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores de Esteroides/genética , Receptores de Hormona Tiroidea/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Espectrometría por Rayos X , Transfección
14.
OMICS ; 17(11): 584-93, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24044365

RESUMEN

The thyroid pathway represents a complex interaction of different glands for thyroid hormone synthesis. Thyrotropin releasing hormone is synthesized in the hypothalamus and regulates thyrotropin stimulating hormone gene expression in the pituitary gland. In order to understand the complexity of the thyroid pathways, and using experimental data retrieved from the biomedical literature (e.g., NCBI, HuGE Navigator, Protein Data Bank, and KEGG), we constructed a metabolic map of the thyroid hormone pathway at a molecular level and analyzed it topologically. A total of five hub nodes were predicted in regards to the transcription thyroid receptor (TR), cAMP response element-binding protein (CREB), signal transducer and activator of transcription 3 (STAT 3), nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB), and activator protein 1 (AP-1) as being potentially important in study of thyroid disorders and as novel putative therapeutic drug targets. Notably, the thyroid receptor is a highly connected hub node and currently used as a therapeutic target in hypothyroidism. Our analysis represents the first comprehensive description of the thyroid pathway, which pertains to understanding the function of the protein and gene interaction networks. The findings from this study are therefore informative for pathophysiology and rational therapeutics of thyroid disorders.


Asunto(s)
Hipotiroidismo/metabolismo , Receptores de Hormona Tiroidea/metabolismo , Transducción de Señal , Glándula Tiroides/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/genética , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Bases de Datos de Proteínas , Regulación de la Expresión Génica , Humanos , Hipotálamo/metabolismo , Hipotiroidismo/genética , Hipotiroidismo/patología , FN-kappa B/genética , FN-kappa B/metabolismo , Hipófisis/metabolismo , Mapeo de Interacción de Proteínas , Receptores de Hormona Tiroidea/genética , Factor de Transcripción STAT3/genética , Factor de Transcripción STAT3/metabolismo , Glándula Tiroides/patología , Tirotropina/genética , Tirotropina/metabolismo , Hormona Liberadora de Tirotropina/genética , Hormona Liberadora de Tirotropina/metabolismo , Factor de Transcripción AP-1/genética , Factor de Transcripción AP-1/metabolismo
15.
Mol Cell Biol ; 33(19): 3826-34, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23897430

RESUMEN

Nuclear receptors (NRs) regulate diverse physiological processes, including the central nervous system control of energy balance. However, the molecular mechanisms for the central actions of NRs in energy balance remain relatively poorly defined. Here we report a hypothalamic gene network involving two NRs, neuron-derived orphan receptor 1 (NOR1) and glucocorticoid receptor (GR), which directs the regulated expression of orexigenic neuropeptides agouti-related peptide (AgRP) and neuropeptide Y (NPY) in response to peripheral signals. Our results suggest that the anorexigenic signal leptin induces NOR1 expression likely via the transcription factor cyclic AMP response element-binding protein (CREB), while the orexigenic signal glucocorticoid mobilizes GR to inhibit NOR1 expression by antagonizing the action of CREB. Also, NOR1 suppresses glucocorticoid-dependent expression of AgRP and NPY. Consistently, relative to wild-type mice, NOR1-null mice showed significantly higher levels of AgRP and NPY and were less responsive to leptin in decreasing the expression of AgRP and NPY. These results identify mutual antagonism between NOR1 and GR to be a key rheostat for peripheral metabolic signals to centrally control energy balance.


Asunto(s)
Proteínas de Unión al ADN/genética , Metabolismo Energético/genética , Redes Reguladoras de Genes , Hipotálamo/metabolismo , Proteínas del Tejido Nervioso/genética , Receptores de Glucocorticoides/genética , Receptores de Esteroides/genética , Receptores de Hormona Tiroidea/genética , Proteína Relacionada con Agouti/genética , Proteína Relacionada con Agouti/metabolismo , Animales , Línea Celular Tumoral , Proteínas de Unión al ADN/metabolismo , Ingestión de Alimentos/genética , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Hibridación in Situ , Leptina/genética , Leptina/metabolismo , Leptina/farmacología , Masculino , Ratones , Ratones Noqueados , Ratones Obesos , Proteínas del Tejido Nervioso/metabolismo , Neuronas/metabolismo , Neuropéptido Y/genética , Neuropéptido Y/metabolismo , Receptores de Glucocorticoides/metabolismo , Receptores de Esteroides/metabolismo , Receptores de Hormona Tiroidea/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
16.
Horm Metab Res ; 43(6): 391-6, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21512963

RESUMEN

1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene (p, p'-dichlorodiphenyldichloroethylene, p, p'-DDE), the major metabolite of 2,2-bis(p-chlorophenyl)-1,1,1-trichloroethane (DDT), is a known persistent organic pollutant and endocrine disrupting toxicant. In recent years, it has attracted many attentions on account of its disturbing effects on thyroid and thyroid hormones (THs). However, the mechanisms by which the p, p'-DDE exposure influences THs still remain uncertain. To elucidate the possible mechanisms, 20 male rats are administered with different doses of p, p'-DDE (0, 20, 60, 100 mg/kg body wt) every other day by intraperitoneal injection for 10 days. The results indicate that after the p, p'-DDE exposure, serum total thyroxine (TT4) and free thyroxine (FT4) are significantly reduced and other THs changed only little. Transthyretin (TTR) declines in serum and thyroid hormone receptors (TRα1 and TRß1) mRNA expressions elevate in hypothalamus. The hepatic enzymes CYP1A1 (EROD), CYP2B1 (PROD), and UDPGTs are significantly upregulated, but CYP1A2 (MROD) does not show significant change. Taken together, the observed effects in the present study show that p, p'-DDE could disturb the homeostasis of THs via TRs increase, TTR decrease, and hepatic enzymes induction.


Asunto(s)
Diclorodifenil Dicloroetileno/toxicidad , Homeostasis/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/enzimología , Prealbúmina/metabolismo , Receptores de Hormona Tiroidea/metabolismo , Hormonas Tiroideas/metabolismo , Animales , Western Blotting , Peso Corporal/efectos de los fármacos , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Glucuronosiltransferasa/genética , Glucuronosiltransferasa/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Masculino , Tamaño de los Órganos/efectos de los fármacos , Prealbúmina/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores de Hormona Tiroidea/genética
17.
Mol Cell Endocrinol ; 323(2): 172-82, 2010 Jul 29.
Artículo en Inglés | MEDLINE | ID: mdl-20399831

RESUMEN

The hypothalamus integrates metabolic and endocrine signals. As such it represents a potential target for a wide spectrum of endocrine disrupting chemicals (EDCs). We investigated hypothalamic effects of two environmentally abundant xenobiotics, the flame-retardant tetrabromo bisphenol A (TBBPA) and the anti-fouling agent tributyltin (TBT). These EDCs affect endocrine signalling through different nuclear receptors including the thyroid hormone receptor (TR) or its partner, the retinoid X receptor (RXR). Promoter sequences of two hypothalamic genes implicated in metabolic control and regulated by thyroid hormone, thyrotropin-releasing hormone (Trh) and type 4 melanocortin receptor (Mc4r), were studied in vivo using reporter assays. Chronic exposure of gestating dams or acute exposure of their newborns to TBBPA abrogated activation of both Trh and Mc4r transcription. Exposure of lactating dams to TBT amplified activation of Trh without affecting Mc4r transcription. Thus, perinatal exposure to EDCs affecting nuclear receptor signalling modulates hypothalamic set-points controlling metabolic responses.


Asunto(s)
Contaminantes Ambientales/farmacología , Estrógenos no Esteroides/farmacología , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Fenoles/farmacología , Hormonas Tiroideas/metabolismo , Compuestos de Trialquiltina/farmacología , Animales , Animales Recién Nacidos , Compuestos de Bencidrilo , Femenino , Genes Reporteros , Homeostasis , Ratones , Embarazo , Regiones Promotoras Genéticas , Receptor de Melanocortina Tipo 4/genética , Receptor de Melanocortina Tipo 4/metabolismo , Receptores de Hormona Tiroidea/genética , Receptores de Hormona Tiroidea/metabolismo , Receptores X Retinoide/genética , Receptores X Retinoide/metabolismo , Transducción de Señal/efectos de los fármacos , Hormonas Tiroideas/genética , Hormona Liberadora de Tirotropina/genética , Hormona Liberadora de Tirotropina/metabolismo , Transcripción Genética
18.
J Biol Chem ; 284(41): 28420-28429, 2009 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-19661066

RESUMEN

Berberine, an alkaloid derivative from Berberis vulgaris L., has been used extensively in traditional Chinese medicine to treat diarrhea and diabetes, but the underlying mechanisms for treating diabetes are not fully understood. Recent studies suggested that berberine has many beneficial biological effects, including anti-inflammation. Because type 1 diabetes is caused by T cell-mediated destruction of beta cells and severe islet inflammation, we hypothesized that berberine could ameliorate type 1 diabetes through its immune regulation properties. Here we reported that 2 weeks of oral administration of berberine prevented the progression of type 1 diabetes in half of the NOD mice and decreased Th17 and Th1 cytokine secretion. Berberine suppressed Th17 and Th1 differentiation by reducing the expression of lineage markers. We found that berberine inhibited Th17 differentiation by activating ERK1/2 and inhibited Th1 differentiation by inhibiting p38 MAPK and JNK activation. Berberine down-regulated the activity of STAT1 and STAT4 through the suppression of p38 MAPK and JNK activation, and it controlled the stability of STAT4 through the ubiquitin-proteasome pathway. Our findings indicate that berberine targets MAPK to suppress Th17 and Th1 differentiation in type 1 diabetic NOD mice. This study revealed a novel role of ERK in Th17 differentiation through down-regulation of STAT3 phosphorylation and RORgamma t expression.


Asunto(s)
Berberina/uso terapéutico , Diferenciación Celular/fisiología , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Interleucina-17/inmunología , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Células TH1/fisiología , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Animales , Berberina/inmunología , Citocinas/inmunología , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/fisiopatología , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Femenino , Humanos , Ganglios Linfáticos/citología , Ganglios Linfáticos/inmunología , Ratones , Ratones Endogámicos NOD , Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares , Receptores de Ácido Retinoico/genética , Receptores de Ácido Retinoico/metabolismo , Receptores de Hormona Tiroidea/genética , Receptores de Hormona Tiroidea/metabolismo , Factor de Transcripción STAT3/genética , Factor de Transcripción STAT3/metabolismo , Bazo/citología , Bazo/inmunología , Células TH1/citología , Células TH1/inmunología
19.
Biochem Biophys Res Commun ; 386(2): 311-5, 2009 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-19523439

RESUMEN

NOR1, Nur77 and Nurr1 are orphan nuclear receptors and members of the NR4A subfamily. Here, we report that the expression of hypothalamic NOR1 was remarkably decreased in mildly obese beta-endorphin-deficient mice and obese db/db mice with the leptin receptor mutation, compared with age-matched wild-type mice, whereas there were no genotypic differences in the expression of hypothalamic Nur77 or Nurr1 in these animals. The injection of NOR1 siRNA oligonucleotide into the third cerebral ventricle significantly suppressed food intake and body weight in mice. On the other hand, the decreases in hypothalamic NOR1 expression were not found in non-obese 5-HT2C receptor-deficient mice. Moreover, systemic administration of m-chlorophenylpiperazine (mCPP), a 5-HT2C/1B receptor agonist, had no effect on hypothalamic NOR1 expression, while suppressing food intake in beta-endorphin-deficient mice. These findings suggest that 5-HT2C receptor-independent proopiomelanocortin-derived peptides regulate the expression of hypothalamic NOR1, which is a novel modulator of feeding behavior and energy balance.


Asunto(s)
Proteínas de Unión al ADN/biosíntesis , Hiperfagia/metabolismo , Hipotálamo/metabolismo , Proteínas del Tejido Nervioso/biosíntesis , Proopiomelanocortina/metabolismo , Receptor de Serotonina 5-HT2C/metabolismo , Receptores de Esteroides/biosíntesis , Receptores de Hormona Tiroidea/biosíntesis , Animales , Proteínas de Unión al ADN/genética , Ingestión de Alimentos , Metabolismo Energético , Hiperfagia/genética , Masculino , Ratones , Ratones Mutantes , Proteínas del Tejido Nervioso/genética , Miembro 1 del Grupo A de la Subfamilia 4 de Receptores Nucleares , Miembro 2 del Grupo A de la Subfamilia 4 de Receptores Nucleares , Piperazinas/farmacología , ARN Interferente Pequeño/genética , Receptor de Serotonina 5-HT2C/genética , Receptores de Esteroides/genética , Receptores de Hormona Tiroidea/genética , Agonistas del Receptor de Serotonina 5-HT2 , Agonistas de Receptores de Serotonina/farmacología , Factores de Transcripción/biosíntesis , betaendorfina/deficiencia , betaendorfina/genética
20.
J Pharmacol Exp Ther ; 329(1): 192-201, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19164466

RESUMEN

Retinoid-related orphan nuclear receptors (RORs) alpha and gamma (NR1F1, -3) are highly expressed in liver, adipose tissue, thymus, and brain and are involved in many physiological processes, such as circadian rhythm and immune function. Enzymes in the cytochrome P450 2C subfamily metabolize many clinically important drugs and endogenous compounds, such as the anticancer drug paclitaxel and arachidonic acid, and are highly expressed in liver. Here, we present the first evidence that RORs regulate the transcription of human CYP2C8. Overexpression of RORalpha and RORgamma in HepG2 cells significantly enhanced the activity of the CYP2C8 promoter but not that of the CYP2C9 or CYP2C19 promoters. Computer analyses, promoter deletion studies, gel shift assays, and mutational analysis identified an essential ROR-responsive element at -2045 base pairs in the CYP2C8 promoter that mediates ROR transactivation. Adenoviral overexpression of RORalpha and -gamma significantly induced endogenous CYP2C8 transcripts in both HepG2 cells and human primary hepatocytes. Knockdown of endogenous RORalpha and -gamma expression in HepG2 cells by RNA interference decreased the expression of endogenous CYP2C8 mRNA by approximately 50%. These data indicate that RORs transcriptionally up-regulate CYP2C8 in human liver and, therefore, may be important modulators of the metabolism of drugs and physiologically active endogenous compounds by this enzyme in liver and possibly extrahepatic tissues where RORs are expressed.


Asunto(s)
Hidrocarburo de Aril Hidroxilasas/genética , Receptores Citoplasmáticos y Nucleares/genética , Receptores de Ácido Retinoico/genética , Receptores de Hormona Tiroidea/genética , Transactivadores/genética , Adenoviridae/genética , Hidrocarburo de Aril Hidroxilasas/fisiología , Western Blotting , Línea Celular , Células Cultivadas , Citocromo P-450 CYP2C8 , ADN Complementario/biosíntesis , ADN Complementario/genética , Ensayo de Cambio de Movilidad Electroforética , Expresión Génica/efectos de los fármacos , Vectores Genéticos , Hepatocitos/fisiología , Humanos , Hígado/enzimología , Miembro 1 del Grupo F de la Subfamilia 1 de Receptores Nucleares , Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares , Plásmidos/genética , Regiones Promotoras Genéticas/genética , ARN Interferente Pequeño/farmacología , Receptores Citoplasmáticos y Nucleares/fisiología , Receptores de Ácido Retinoico/fisiología , Receptores de Hormona Tiroidea/fisiología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transactivadores/fisiología , Activación Transcripcional , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA